Abstract
Objective To study the prevalence of maternal depressive symptoms in the immediate postpartum period (≤ 7 days postpartum) during the COVID-19 pandemic and to identify associated factors.
Methods We performed a cross-sectional analytical study. The study population consisted of postpartum women >18 years old enrolled at the Municipal University Hospital of São Bernardo do Campo. The Edinburgh Postnatal Depression Scale and a questionnaire on sociodemographic characteristics and clinical history were administered to 90 patients in the first week of the immediate postpartum period between June and December 2021.
Results An Edinburgh Postnatal Depression Scale score > 10 was observed in 39 (43.3%) of the postpartum women. From a multivariate analysis, the factors associated with a score > 10 on the scale were: “having no belief/spirituality” with 83% (95% CI 1.20-2.81, p<0.006), “having had more than one pregnancy” with 50% (95% CI 0.29-0.89, p<0.02), “having a previous episode of depression” with 64% (95% CI 1.02-2.65, p<0.04), and “having a previous episode of anxiety” with 83% (95% CI 1.06-3.16, p<0.03). The other factors studied did not have statistical significance.
Conclusion With the COVID-19 pandemic, an increase in the prevalence of depressive symptoms in the immediate postpartum period was observed. The postpartum women who scored > 10 on the EPDS had the following common associated factors: “having no belief/spirituality”, “having had more than one pregnancy”, “having a previous episode of depression”, and “having a previous episode of anxiety”. These findings indicate the need for greater attention from health professionals to these positive factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Faculty of Medicine of ABC University Center gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
